医疗保健生物融合市场规模、份额、趋势分析报告：按应用、地区、细分市场预测，2025-2030 年

Healthcare Bioconvergence Market Size, Share & Trends Analysis Report By Application, By Region, and Segment Forecasts, 2025 - 2030

出版日期: 2024年11月05日 | 出版商:

Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

医疗保健生物融合市场成长与趋势

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球医疗保健生物融合市场规模预计将达到 2,152 亿美元。

由于老年人数量不断增加、干细胞技术在修復受损细胞、组织和器官、机器人技术、机械技术等方面的优势，该市场预计从 2025 年到 2030 年将以 6.7% 的复合年增长率扩张。科技科技与学习、智慧成像、人体工学（个人与环境之间的关係）、人工智慧和生命科学的进步相结合。除了医学之外，生物融合也应用于农业、能源、食品、安全和气候等各个领域。

COVID-19 大流行对药物研究、卫生技术和医疗技术产生了重大影响。将人工智慧和机器学习等高科技技术融入生物技术研发部门，有助于了解病原体并开发药物和疫苗，以遏制病毒在世界各地的传播。先进工程、生物学、物理学和计算科学的融合极大地加快了药物开发的步伐。根据 2021 年学术论文《医学前沿》，人工智慧等先进技术正在帮助 COVID-19 的高效诊断、预后测试、流行病预测和药物发现。

随着数位化进步的接受，云端基础的解决方案可能会在製药业以指数速度发展。再生医学透过融合生命科学、先进工程、机器人技术、电脑科学、自动化和专业知识来持续发展，为体内修復提供要素。

医疗保健生物融合市场报告亮点

按应用来看，药物发现预计将在 2024 年占据市场主导地位，收益占有率为 20.46%，2025 年至 2030 年复合年增长率最快为 8.2%。背后的原因包括神经系统和循环系统疾病等多种疾病的发病率增加、医疗费用上涨以及普通药品专利到期。
再生医学领域因其在治疗帕金森氏症、阿兹海默症、脑损伤组织修復等慢性病以及透过靶向、特异性、精准药物治疗慢性病方面的突出潜力，预计将在2025年实现增长到2030 年，交付量可能会创下8.7% 的最快复合年增长率。
2024年，欧洲将以30.13%的收益占有率主导市场。这是由于领先的研究机构、医院和医疗中心的存在，为识别和创造创新的医学科学治疗方法提供了坚实的基础。

The global healthcare bioconvergence market size is expected to reach USD 215.2 billion by 2030, based on a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 6.7% from 2025 to 2030, owing to factors including the growing geriatric population, rising stem cell technology regarding the advantages of fixing damaged cells, tissues as well as organs, and the integration of high-tech technologies and advancements such as robotics, machine learning, intelligent imaging, ergonomics (relationship between individuals and their environment), and artificial intelligence with life science. Besides healthcare, bioconvergence is finding applications in a variety of other areas as well, including agriculture, energy, food, security, climate, and others.

The COVID-19 pandemic has significantly impacted medication research, health technology, and medical technology. The incorporation of high-tech technologies such as AI and ML into the biotech research and development sector aided in understanding the pathogen and developing drugs as well as vaccines to control the spread of the virus across the globe. The amalgamation of advanced engineering, biology, physics, and computational sciences, has significantly increased the pace of drug development. According to the 2021 academic paper Frontiers in Medicine, advanced technologies such as AI have helped in efficient diagnosis, prognosis examination, epidemic prediction, and drug discovery for COVID-19.

With the rise in terms of acceptance of digital advancements, cloud-based solutions are likely to evolve in the pharmaceutical industry at an exponential pace. Regenerative medicine is evolving by merging expertise knowledge with life science, advanced engineering, robotics, computer science, and automation to provide elements for in-vivo repair.

Healthcare Bioconvergence Market Report Highlights:

Based on application, drug discovery dominates dominated the market in terms of the revenue share of 20.46% in 2024 and is expected to witness the fastest CAGR of 8.2% from 2025 to 2030. This is attributable to the growing frequency of a broad range of ailments (such as nervous system-related disorders, and circulatory disorders), mounting medical costs, as well as the approaching patent termination of popular drugs
The regenerative medicine segment is likely to witness the fastest CAGR of 8.7% from 2025 to 2030 owing to its exceptional potential to treat chronic diseases such as Parkinson's disease, Alzheimer's disease, brain injury tissue repair, and to treat chronic diseases by target-oriented, and site-specific delivery of precise drugs
In 2024, Europe dominated the market with a revenue share of 30.13%, owing to the presence of leading research institutes, hospitals, and medical centers which serve a solid basis for identifying and creating innovative medical and scientific treatments

Chapter 1 Report Scope and Objectives

1.1 Market Segmentation & Scope
1.2 Regional Scope
- 1.2.1 Estimates And Forecast Timeline
1.3 Objectives
- 1.3.1 Objective - 1
- 1.3.2 Objective - 2
- 1.3.3 Objective - 3

Chapter 2 Methodology

2.1 Research Methodology
2.2 Information Procurement
- 2.2.1 Purchased Database
- 2.2.2 GVR's Internal Database
- 2.2.3 Secondary Sources
- 2.2.4 Primary Research
2.3 Information Or Data Analysis
- 2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
- 2.5.1 Commodity Flow Analysis (Model 1)
- 2.5.2 Volume Price Analysis (Model 2)
2.6 List Of Secondary Sources

Chapter 3 Executive Summary

3.1 Market Outlook
3.2 Segment Outlook
- 3.2.1 Application
- 3.2.4 Region
3.3 Competitive Insights
3.4 Healthcare Bioconvergence Market Outlook, 2024

Chapter 4 Market Variables, Trends & Scope

4.1 Market Lineage Outlook
- 4.1.1 Parent Market Outlook
4.2 Healthcare Bioconvergence Market Dynamics
- 4.2.1 Market Driver Analysis
- 4.2.2 Market Restraint Analysis
4.3 Healthcare Bioconvergence: Business Environment Analysis Tools
- 4.3.1 Porter's Five Forces Analysis
  - 4.3.1.1 Competitive Rivalry
  - 4.3.1.2 Threat Of Substitutes
  - 4.3.1.3 Threat Of Entrants
  - 4.3.1.4 Bargaining Power Of Buyers
  - 4.3.1.5 Bargaining Power Of Suppliers
- 4.3.2 Pestel Analysis
  - 4.3.2.1 Political & Legal
  - 4.3.2.2 Economic & Social
  - 4.3.2.3 Technological
4.4 Penetration & Growth Prospect Mapping
4.5 Impact Of COVID-19 On Healthcare Bioconvergence Market

Chapter 5 Healthcare Bioconvergence Market: Application Analysis

5.1 Healthcare Bioconvergence Application Market Share Analysis, 2024 & 2030
5.2 Healthcare Bioconvergence Application Market: Segment Dashboard
5.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Application Segment
- 5.3.1 Drug Discovery
  - 5.3.1.1 Drug Discovery Market, 2018 - 2030 (USD Million)
- 5.3.2 Nanorobotics For Drug Delivery
  - 5.3.2.1 Nanorobotics For Drug Delivery Market, 2018 - 2030 (USD Million)
- 5.3.3 Regenerative Medicine
  - 5.3.3.1 Regenerative Medicine Market, 2018 - 2030 (USD Million)
- 5.3.4 Diagnostic And Biological Sensors
  - 5.3.4.1 Diagnostic And Biological Sensors Market, 2018 - 2030 (USD Million)
- 5.3.5 Bioelectronics
  - 5.3.5.1 Bioelectronics Market, 2018 - 2030 (USD Million)
- 5.3.6 Engineered Living Materials
  - 5.3.6.1 Engineered Living Materials Market, 2018 - 2030 (USD Million)
- 5.3.7 Optogenetics
  - 5.3.7.1 Optogenetics Market, 2018 - 2030 (USD Million)
- 5.3.8 Precision Medicine
  - 5.3.8.1 Precision Medicine Market, 2018 - 2030 (USD Million)

Chapter 6 Healthcare Bioconvergence Market: Regional Analysis

6.1 Healthcare Bioconvergence Regional Market Share Analysis, 2024 & 2030
6.2 Regional Market Snapshot
6.3 North America
- 6.3.1 North America Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.2 U.S.
  - 6.3.2.1 U.S. Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.3 Canada
  - 6.3.3.1 Canada Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.4 Mexico
  - 6.3.4.1 Mexico Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
6.4 Europe
- 6.4.1 Europe Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.2 UK
  - 6.4.2.1 UK Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.3 Germany
  - 6.4.3.1 Germany Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.4 France
  - 6.4.4.1 France Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.5 Italy
  - 6.4.5.1 Italy Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.6 Spain
  - 6.4.6.1 Spain Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.4.7 Russia
  - 6.4.7.1 Russia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.8 Denmark
  - 6.3.8.1 Denmark Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.9 Sweden
  - 6.3.9.1 Sweden Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.3.10 Norway
  - 6.3.10.1 Norway Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
6.5 Asia Pacific
- 6.5.1 Asia Pacific Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.2 Japan
  - 6.5.2.1 Japan Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.3 China
  - 6.5.3.1 China Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.4 India
  - 6.5.4.1 India Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.5 Australia
  - 6.5.5.1 Australia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.6 South Korea
  - 6.5.6.1 South Korea Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.7 Singapore
  - 6.5.7.1 Singapore Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.5.8 Thailand
  - 6.5.8.1 Thailand Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
6.6 Latin America
- 6.6.1 Latin America Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.6.2 Brazil
  - 6.6.2.1 Brazil Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.6.3 Mexico
  - 6.6.3.1 Mexico Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.6.4 Argentina
  - 6.6.4.1 Argentina Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.6.5 Colombia
  - 6.6.5.1 Colombia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
6.7 Middle East And Africa (MEA)
- 6.7.1 MEA Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.7.2 South Africa
  - 6.7.2.1 South Africa Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.7.3 Saudi Arabia
  - 6.7.3.1 Saudi Arabia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.7.4 UAE
  - 6.7.4.1 UAE Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.7.5 Israel
  - 6.7.5.1 Israel Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
- 6.7.6 Kuwait
  - 6.7.6.1 Kuwait Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis

7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Profiles
- 7.2.1 Biomx.
  - 7.2.1.1 Company Overview
  - 7.2.1.2 Financial Performance
  - 7.2.1.2 Product Benchmarking
  - 7.2.1.3 Strategic Initiatives
- 7.2.2 Singota Solution
  - 7.2.2.1 Company Overview
  - 7.2.2.2 Product Benchmarking
- 7.2.3 Anima Biotech Inc.
  - 7.2.3.1 Company Overview
  - 7.2.3.3 Product Benchmarking
- 7.2.4 Ginkgo Bioworks
  - 7.2.4.1 Company Overview
  - 7.2.4.2 Product Benchmarking
  - 7.2.4.3 Strategic Initiatives
- 7.2.5 Setpoint Medical Corporation
  - 7.2.5.1 Company Overview
  - 7.2.5.2 Product Benchmarking
  - 7.2.5.3 Strategic Initiatives
- 7.2.6 Galvani Bioelectronics
  - 7.2.6.1 Company Overview
  - 7.2.6.2 Product Benchmarking
- 7.2.7 Bico - The Bio Convergence Company
  - 7.2.7.1 Company Overview
  - 7.2.7.2 Financial Performance
  - 7.2.7.3 Product Benchmarking
  - 7.2.7.4 Strategic Initiatives

简介目录图表

List of Tables

Table 1 List of secondary sources
Table 2 North America healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 3 North America healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 4 U.S. healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 5 Canada healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 6 Mexico healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 7 Europe healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 8 Europe healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 9 UK healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 10 Germany healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 11 France healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 12 Italy healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 13 Spain healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 14 Russia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 15 Denmark healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 16 Sweden healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 17 Norway healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 18 Asia Pacific healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 19 Asia Pacific healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 20 Japan healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 21 China healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 22 India healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 23 Australia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 24 South Korea healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 25 Singapore healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 26 Thailand healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 27 Latin America healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 28 Latin America healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 29 Brazil healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 30 Argentina healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 31 Colombia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 32 MEA healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
Table 33 MEA healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 34 South Africa healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 35 Saudi Arabia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 36 UAE healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 37 Israel healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 38 Kuwait healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Healthcare bioconvergence market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Healthcare bioconvergence market outlook, 2024 (USD Million)
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Healthcare bioconvergence application market share analysis, 2024 & 2030 (USD Million)
Fig. 15 Healthcare bioconvergence application market: Segment dashboard
Fig. 16 Drug discovery market, 2018 - 2030 (USD Million)
Fig. 17 Nanorobotics for drug delivery market, 2018 - 2030 (USD Million)x1
Fig. 18 Regenerative medicine market, 2018 - 2030 (USD Million)
Fig. 19 Diagnostic and biological sensors market, 2018 - 2030 (USD Million)
Fig. 20 Bioelectronics market, 2018 - 2030 (USD Million)
Fig. 21 Engineered living materials market, 2018 - 2030 (USD Million)
Fig. 22 Optogenetics market, 2018 - 2030 (USD Million)
Fig. 23 Precision medicine health market, 2018 - 2030 (USD Million)
Fig. 24 Healthcare bioconvergence regional market share analysis, 2021 & 2030 (USD Million)
Fig. 25 Regional market place: Key takeaways
Fig. 26 North America healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 27 U.S. healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 28 Canada healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 29 Mexico healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 30 Europe healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 31 UK healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 32 Germany healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 33 France healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 34 Italy healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 35 Spain healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 36 Russia healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 37 Denmark healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 38 Sweden healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 39 Norway healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 40 Asia Pacific healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 41 Japan healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 42 China healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 43 India healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 44 Australia healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 45 South Korea healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 46 Singapore healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 47 Thailand healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 48 Latin America healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 49 Brazil healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 50 Argentina healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 51 Colombia healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 52 MEA healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 53 South Africa healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 55 UAE healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 56 Israel healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 57 Israel healthcare bioconvergence market, 2018 - 2030 (USD Million)
Fig. 58 Strategy framework